These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34545366)

  • 21. A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge.
    Yahalom-Ronen Y; Tamir H; Melamed S; Politi B; Shifman O; Achdout H; Vitner EB; Israeli O; Milrot E; Stein D; Cohen-Gihon I; Lazar S; Gutman H; Glinert I; Cherry L; Vagima Y; Lazar S; Weiss S; Ben-Shmuel A; Avraham R; Puni R; Lupu E; Bar-David E; Sittner A; Erez N; Zichel R; Mamroud E; Mazor O; Levy H; Laskar O; Yitzhaki S; Shapira SC; Zvi A; Beth-Din A; Paran N; Israely T
    Nat Commun; 2020 Dec; 11(1):6402. PubMed ID: 33328475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a Synthetic Poxvirus-Based SARS-CoV-2 Vaccine.
    Chiuppesi F; Salazar MD; Contreras H; Nguyen VH; Martinez J; Park S; Nguyen J; Kha M; Iniguez A; Zhou Q; Kaltcheva T; Levytskyy R; Ebelt ND; Kang TH; Wu X; Rogers T; Manuel ER; Shostak Y; Diamond DJ; Wussow F
    bioRxiv; 2020 Jul; ():. PubMed ID: 32637957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman Primates.
    Francica JR; Flynn BJ; Foulds KE; Noe AT; Werner AP; Moore IN; Gagne M; Johnston TS; Tucker C; Davis RL; Flach B; O'Connell S; Andrew SF; Lamb E; Flebbe DR; Nurmukhambetova ST; Donaldson MM; Todd JM; Zhu AL; Atyeo C; Fischinger S; Gorman MJ; Shin S; Edara VV; Floyd K; Lai L; Tylor A; McCarthy E; Lecouturier V; Ruiz S; Berry C; Tibbitts T; Andersen H; Cook A; Dodson A; Pessaint L; Ry AV; Koutsoukos M; Gutzeit C; Teng IT; Zhou T; Li D; Haynes BF; Kwong PD; McDermott A; Lewis MG; Fu TM; Chicz R; van der Most R; Corbett KS; Suthar MS; Alter G; Roederer M; Sullivan NJ; Douek DC; Graham BS; Casimiro D; Seder RA
    bioRxiv; 2021 Mar; ():. PubMed ID: 33688652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19.
    Malherbe DC; Kurup D; Wirblich C; Ronk AJ; Mire C; Kuzmina N; Shaik N; Periasamy S; Hyde MA; Williams JM; Shi PY; Schnell MJ; Bukreyev A
    NPJ Vaccines; 2021 Jul; 6(1):91. PubMed ID: 34294728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.
    Tscherne A; Schwarz JH; Rohde C; Kupke A; Kalodimou G; Limpinsel L; Okba NMA; Bošnjak B; Sandrock I; Odak I; Halwe S; Sauerhering L; Brosinski K; Liangliang N; Duell E; Jany S; Freudenstein A; Schmidt J; Werner A; Gellhorn Serra M; Klüver M; Guggemos W; Seilmaier M; Wendtner CM; Förster R; Haagmans BL; Becker S; Sutter G; Volz A
    Proc Natl Acad Sci U S A; 2021 Jul; 118(28):. PubMed ID: 34162739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A SARS-CoV-2 spike ferritin nanoparticle vaccine protects against heterologous challenge with B.1.1.7 and B.1.351 virus variants in Syrian golden hamsters.
    Wuertz KM; Barkei EK; Chen WH; Martinez EJ; Lakhal-Naouar I; Jagodzinski LL; Paquin-Proulx D; Gromowski GD; Swafford I; Ganesh A; Dong M; Zeng X; Thomas PV; Sankhala RS; Hajduczki A; Peterson CE; Kuklis C; Soman S; Wieczorek L; Zemil M; Anderson A; Darden J; Hernandez H; Grove H; Dussupt V; Hack H; de la Barrera R; Zarling S; Wood JF; Froude JW; Gagne M; Henry AR; Mokhtari EB; Mudvari P; Krebs SJ; Pekosz AS; Currier JR; Kar S; Porto M; Winn A; Radzyminski K; Lewis MG; Vasan S; Suthar M; Polonis VR; Matyas GR; Boritz EA; Douek DC; Seder RA; Daye SP; Rao M; Peel SA; Joyce MG; Bolton DL; Michael NL; Modjarrad K
    bioRxiv; 2021 Jun; ():. PubMed ID: 34159328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19 disease in hamsters.
    Jia Q; Bielefeldt-Ohmann H; Maison R; Masleša-Galić S; Bowen R; Horwitz MA
    bioRxiv; 2020 Nov; ():. PubMed ID: 33236013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A single intranasal dose of human parainfluenza virus type 3-vectored vaccine induces effective antibody and memory T cell response in the lungs and protects hamsters against SARS-CoV-2.
    Ilinykh PA; Periasamy S; Huang K; Kuzmina NA; Ramanathan P; Meyer MN; Mire CE; Kuzmin IV; Bharaj P; Endsley JR; Chikina M; Sealfon SC; Widen SG; Endsley MA; Bukreyev A
    NPJ Vaccines; 2022 Apr; 7(1):47. PubMed ID: 35468973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.
    Li M; Guo J; Lu S; Zhou R; Shi H; Shi X; Cheng L; Liang Q; Liu H; Wang P; Wang N; Wang Y; Fu L; Xing M; Wang R; Ju B; Liu L; Lau SY; Jia W; Tong X; Yuan L; Guo Y; Qi H; Zhang Q; Huang Z; Chen H; Zhang Z; Chen Z; Peng X; Zhou D; Zhang L
    Front Immunol; 2021; 12():697074. PubMed ID: 34262569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge.
    Wuertz KM; Barkei EK; Chen WH; Martinez EJ; Lakhal-Naouar I; Jagodzinski LL; Paquin-Proulx D; Gromowski GD; Swafford I; Ganesh A; Dong M; Zeng X; Thomas PV; Sankhala RS; Hajduczki A; Peterson CE; Kuklis C; Soman S; Wieczorek L; Zemil M; Anderson A; Darden J; Hernandez H; Grove H; Dussupt V; Hack H; de la Barrera R; Zarling S; Wood JF; Froude JW; Gagne M; Henry AR; Mokhtari EB; Mudvari P; Krebs SJ; Pekosz AS; Currier JR; Kar S; Porto M; Winn A; Radzyminski K; Lewis MG; Vasan S; Suthar M; Polonis VR; Matyas GR; Boritz EA; Douek DC; Seder RA; Daye SP; Rao M; Peel SA; Joyce MG; Bolton DL; Michael NL; Modjarrad K
    NPJ Vaccines; 2021 Oct; 6(1):129. PubMed ID: 34711815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intranasal immunization with avian paramyxovirus type 3 expressing SARS-CoV-2 spike protein protects hamsters against SARS-CoV-2.
    Park HS; Matsuoka Y; Luongo C; Yang L; Santos C; Liu X; Ahlers LRH; Moore IN; Afroz S; Johnson RF; Lafont BAP; Dorward DW; Fischer ER; Martens C; Samal SK; Munir S; Buchholz UJ; Le Nouën C
    NPJ Vaccines; 2022 Jun; 7(1):72. PubMed ID: 35764659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Full-Lung Prophylaxis against SARS-CoV-2 by One-Shot or Booster Intranasal Lentiviral Vaccination in Syrian Golden Hamsters.
    Vesin B; Authié P; Blanc C; Fert I; Noirat A; Le Chevalier F; Wei Y; Ku MW; Nemirov K; Anna F; Hardy D; Planchais C; Mouquet H; Guinet F; Charneau P; Majlessi L; Bourgine M
    Vaccines (Basel); 2022 Dec; 11(1):. PubMed ID: 36679857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity and protective efficacy of BBV152, whole virion inactivated SARS- CoV-2 vaccine candidates in the Syrian hamster model.
    Mohandas S; Yadav PD; Shete-Aich A; Abraham P; Vadrevu KM; Sapkal G; Mote C; Nyayanit D; Gupta N; Srinivas VK; Kadam M; Kumar A; Majumdar T; Jain R; Deshpande G; Patil S; Sarkale P; Patil D; Ella R; Prasad SD; Sharma S; Ella KM; Panda S; Bhargava B
    iScience; 2021 Feb; 24(2):102054. PubMed ID: 33521604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preclinical evaluation of a candidate naked plasmid DNA vaccine against SARS-CoV-2.
    Lassaunière R; Polacek C; Gram GJ; Frische A; Tingstedt JL; Krüger M; Dorner BG; Cook A; Brown R; Orekov T; Putmon-Taylor T; Campbell TA; Greenhouse J; Pessaint L; Andersen H; Lewis MG; Fomsgaard A
    NPJ Vaccines; 2021 Dec; 6(1):156. PubMed ID: 34930909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection.
    Boulton S; Poutou J; Gill R; Alluqmani N; He X; Singaravelu R; Crupi MJF; Petryk J; Austin B; Angka L; Taha Z; Teo I; Singh S; Jamil R; Marius R; Martin N; Jamieson T; Azad T; Diallo JS; Ilkow CS; Bell JC
    Mol Ther Methods Clin Dev; 2023 Dec; 31():101110. PubMed ID: 37822719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral Vaccination Protects Against Severe Acute Respiratory Syndrome Coronavirus 2 in a Syrian Hamster Challenge Model.
    Johnson S; Martinez CI; Tedjakusuma SN; Peinovich N; Dora EG; Birch SM; Kajon AE; Werts AD; Tucker SN
    J Infect Dis; 2022 Jan; 225(1):34-41. PubMed ID: 34758086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nucleocapsid vaccine elicits spike-independent SARS-CoV-2 protective immunity.
    Matchett WE; Joag V; Stolley JM; Shepherd FK; Quarnstrom CF; Mickelson CK; Wijeyesinghe S; Soerens AG; Becker S; Thiede JM; Weyu E; O'Flanagan S; Walter JA; Vu MN; Menachery VD; Bold TD; Vezys V; Jenkins MK; Langlois RA; Masopust D
    bioRxiv; 2021 Apr; ():. PubMed ID: 33948591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity.
    Yang J; Wang W; Chen Z; Lu S; Yang F; Bi Z; Bao L; Mo F; Li X; Huang Y; Hong W; Yang Y; Zhao Y; Ye F; Lin S; Deng W; Chen H; Lei H; Zhang Z; Luo M; Gao H; Zheng Y; Gong Y; Jiang X; Xu Y; Lv Q; Li D; Wang M; Li F; Wang S; Wang G; Yu P; Qu Y; Yang L; Deng H; Tong A; Li J; Wang Z; Yang J; Shen G; Zhao Z; Li Y; Luo J; Liu H; Yu W; Yang M; Xu J; Wang J; Li H; Wang H; Kuang D; Lin P; Hu Z; Guo W; Cheng W; He Y; Song X; Chen C; Xue Z; Yao S; Chen L; Ma X; Chen S; Gou M; Huang W; Wang Y; Fan C; Tian Z; Shi M; Wang FS; Dai L; Wu M; Li G; Wang G; Peng Y; Qian Z; Huang C; Lau JY; Yang Z; Wei Y; Cen X; Peng X; Qin C; Zhang K; Lu G; Wei X
    Nature; 2020 Oct; 586(7830):572-577. PubMed ID: 32726802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Self-amplifying mRNA SARS-CoV-2 vaccines raise cross-reactive immune response to variants and prevent infection in animal models.
    Palladino G; Chang C; Lee C; Music N; De Souza I; Nolasco J; Amoah S; Suphaphiphat P; Otten GR; Settembre EC; Wen Y
    Mol Ther Methods Clin Dev; 2022 Jun; 25():225-235. PubMed ID: 35345593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.